Seroresponse and postvaccination seroprotection based on the CD4 count at vaccination
| . | Seroresponse (n = 100) . | Postvaccination seroprotection (n = 101) . | ||||
|---|---|---|---|---|---|---|
| CD4 ≤ 350, n (%) n = 35 . | CD4 > 350, n (%) n = 65 . | P value . | CD4 ≤ 350, n (%) n = 35 . | CD4 > 350, n (%) n = 66 . | P value . | |
| A | 28 (80.0%) | 58 (89.2%) | .23 | 33 (94.3%) | 64 (97.0%) | .61 |
| C | 27 (77.1%) | 51 (78.5%) | 1 | 29 (82.9%) | 58 (87.9%) | .55 |
| W | 29 (82.9%) | 54 (83.1%) | 1 | 31 (88.6%) | 58 (87.9%) | 1 |
| Y | 23 (65.7%) | 45 (69.2%) | .82 | 25 (71.4%) | 52 (78.8%) | .46 |
| . | Seroresponse (n = 100) . | Postvaccination seroprotection (n = 101) . | ||||
|---|---|---|---|---|---|---|
| CD4 ≤ 350, n (%) n = 35 . | CD4 > 350, n (%) n = 65 . | P value . | CD4 ≤ 350, n (%) n = 35 . | CD4 > 350, n (%) n = 66 . | P value . | |
| A | 28 (80.0%) | 58 (89.2%) | .23 | 33 (94.3%) | 64 (97.0%) | .61 |
| C | 27 (77.1%) | 51 (78.5%) | 1 | 29 (82.9%) | 58 (87.9%) | .55 |
| W | 29 (82.9%) | 54 (83.1%) | 1 | 31 (88.6%) | 58 (87.9%) | 1 |
| Y | 23 (65.7%) | 45 (69.2%) | .82 | 25 (71.4%) | 52 (78.8%) | .46 |